+
Site Tour
EPIC™ MITRAL AND AORTIC TISSUE VALVES
SURGICAL VALVE SOLUTIONS

 

Excellent hemodynamic performance, lasting durability, and a design that preserves future valve-in-valve treatment options.*

10-plus-year aortic valve durability in over 15,000 patients

Biocor™ valve

20-year freedom from
reoperation from structural
valve deterioration (SVD) 1


Munich, Germany
1985–1996

Epic™ Supra valve

10-year freedom from
all-cause reintervention2



U.S. real-world data
2008–2019

Epic™ Supra valve

10-year freedom from SVD,
all patient ages3



Leipzig, Germany
2001–2017

Epic™ Aortic valve and Epic™ Supra valve
15-year freedom from SVD,
reoperation from structural
all patient ages4


Rennes, France
2001–2018

Benefits of the Epic™ Elite valve

Excellent hemodynamics

Maximizing the internal orifice provides large, effective orifice areas (EOAs) and low gradients to reduce the burden on the heart and contribute to better patient outcomes.

Implant with ease

The Epic™ Elite valve was engineered with a flexible polymer stent to allow easy passage through all anatomies.

The ability of the adaptive cuff to compress enables a larger valve to be implanted while also preventing paravalvular leakage (PVL) by sealing in all planes and minimizing parachuting resistance when delivering the valve onto the annulus.

 

Estimated Epic™ Elite valve pressure gradients at one year (mm Hg)5

Mean pressure gradient predicted based on stent equivalency of Biocor™/Epic™ valves

BRINGING YOU...

Clinical Case clubs | Educational tools | Hot topics
Expert opinions | Live & online discussions

 

TV

References

*The safety and effectiveness of valve-in-valve procedures in Epic Valves has not been established.

  1. Eichinger WB, Hettich IM, Ruzicka DJ, Holper K, Schricker C, Bleiziffer S, Lange R. Twenty-year experience with the St. Jude medical Biocor bioprosthesis in the aortic position. Ann Thorac Surg. 2008 Oct;86(4):1204-10. doi: 10.1016/j.athoracsur.2008.05.058. PMID: 18805161. 
  2. Wiechmann RJ, et. al. Ten-year Outcomes of Surgical Aortic Valve Replacement with a Contemporary Supra Annular Porcine Valve in a Medicare Population. JTCVS Open. 2022, https://doi.org/10.1016/j.xjon.2022.08.002.
  3. Jawad K, Lehmann S, Koziarz A, Dieterlen M, Feder S, Misfeld M, Garbade J, Rao V, Borger M. “Midterm results after St Jude Medical Epic porcine xenograft for aortic, mitral, and double valve replacement.” Journal of Cardiac Surgery 35, no. 8 (2020): 1769-1777.
  4. Anselmi A, et al. "Porcine bioprostheses for surgical aortic valve replacement: very long-term performance of a third-generation device." Journal of Cardiovascular Medicine 24, no. 8 (2023): 514-521.J.
  5. [a] Epic Elite Instructions for Use [b] Maitland A, Hirsch G, Pascoe E. “Hemodynamic Performance of the St. Jude Medical Epic™ Supra Aortic Stented Valve.” Journal of Heart Valve disease 20.3 (2011): 327.

© Abbott 2026. All rights reserved. MAT-2682530 v1.0

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline